Andrew Lowy, MD
Surgical Oncology · San Diego, CANPI 1346218179
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $9,701 of the $11,570 with a category attached, or 83.8%. 5 manufacturers reported payments, led by Merck at 37.0% of the total. Reporting peaked in 2020 at $4,429 and has fallen 93.6% since, to $282 in 2024.
Across 25 payments — averaging $462.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$4K
- Boehringer Ingelheim$3K
- Bayer$2K
- Corcept Therapeutics$1K
- AbbVie$1K
Across 9 payments — averaging $8927.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$80K
What the payments were for
- Consulting fees$9,70184%
- Travel & lodging$2903%
- Food & beverage$1,57914%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 4 | $4,281 |
| Boehringer Ingelheim | 6 | $2,850 |
| Bayer | 1 | $1,686 |
| Corcept Therapeutics | 2 | $1,425 |
| AbbVie | 12 | $1,328 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,570 in reported general payments places this provider in the 80th percentile of 209 surgical oncology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgical oncology in San Diego
- Afshin BahadorSan Diego$701K
- Michael BouvetSan Diego$118K
- Amir FathiFresno$255K
- Alexander ChristSanta Monica$239K
- Yanghee WooDuarte$131K
- Yuman FongDuarte$87K
- Ronald HurstLos Angeles$76K
- Jason Sicklickla Jolla$69K
- Mohammed Al-TemimiSan Jose$39K
- Gagandeep SinghDuarte$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.